"So changing the endpoints when you fail to meet them -- that's ok?? Create a recurrent OS endpoint after the fact?? That's ok??
Well...funny you should say that, YES it is, our trial was an adaptive trial and the endpoints were changed PRIOR to unblinding, Like it or not, nothing wrong with this at all and the reason the RA's all accepted the changes and changed their clinical trial sites accordingly.
Market Data 
Markets 
AI
